Shukra Pharmaceuticals Ltd — Important, 07-01-2026: Company Update

The company has received a compliance certificate from its Registrar and Transfer Agent regarding share dematerialisation activities for the quarter ended December 31, 2025. This certificate confirms that all securities received for dematerialisation were processed correctly, accepted or rejected, and that associated physical certificates were duly mutilated and cancelled, with depository names updated in the register of members within prescribed timelines. The report also notes that no share certificates were dematerialised during this specific quarter, reflecting the company's adherence to investor services and record-keeping protocols.